Several researchers have proposed that leukemia-specific T cells (mLSTs) specifically recognize multiple antigens expressed by AML cells, such as PRAME and WT1, compared with DLI. GVHD is minimized to low levels by mLSTs, which even have little to no effect in killing receptor normal cells. Here, PRAME is linked to acute myeloid leukemia.